-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
June 01, 2012 - Meta-analyzing each metric across studies will create summaries that are inconsistent with these formulas … Deciding Which Metrics To Meta-analyze (2 of 6)
This figure illustrates the strategy for meta-analyzing … Why can directly meta-analyzing positive and negative likelihood ratios be problematic? … Recommended Algorithm
A three-step algorithm is recommended for meta-analyzing studies of medical test … range of prevalence values) from summary estimates of sensitivity and specificity, rather than meta-analyzing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
June 01, 2012 - Meta-analyzing each metric across studies will create summaries that are inconsistent with these formulas … Deciding Which Metrics To Meta-analyze (2 of 6)
This figure illustrates the strategy for meta-analyzing … Why can directly meta-analyzing positive and negative likelihood ratios be problematic? … Recommended Algorithm
A three-step algorithm is recommended for meta-analyzing studies of medical test … range of prevalence values) from summary estimates of sensitivity and specificity, rather than meta-analyzing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - of a web based drug
effectiveness reporting and monitoring system that builds on previous studies analyzing … database is available for download by clinical reviewers and researchers on a quarterly basis
for analyzing … Previous Work
Several studies have been conducted analyzing the use of Information Technology (IT) … There is relatively limited literature analyzing the use
of information technology for large scale
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - of a web based drug
effectiveness reporting and monitoring system that builds on previous studies analyzing … database is available for download by clinical reviewers and researchers on a quarterly basis
for analyzing … Previous Work
Several studies have been conducted analyzing the use of Information Technology (IT) … There is relatively limited literature analyzing the use
of information technology for large scale
-
effectivehealthcare-admin.ahrq.gov/products/methods
March 01, 2022 - risk-of-bias assessment; selecting risk of bias categories; choosing assessment instruments; and conducting, analyzing
-
effectivehealthcare-admin.ahrq.gov/health-topics/metabolic-disorders?page=1
June 05, 2013 - Comparative Effectiveness
Overview May 3, 2012
Symposium on Methods for Developing and Analyzing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-270-bimp-disposition-comments.pdf
September 18, 2024 - Evidence-based Practice Center Systematic Review Protocol
Comparative Effectiveness Review Disposition of Comments Report
Title: Behavioral Interventions for Migraine Prevention
Draft report available for public comment from September 5, 2023, to October 20, 2023.
Citation: Treadwell…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s166.pdf
October 01, 2007 - This method of analyzing indirect comparisons is sim-
ple and straightforward and preserves the randomization … We combined
these studies and the 3-arm trials (ie, trials analyzing BNZ,
NBNZ, and placebo) included … In the current study, the indirect estimate included only 2-arm
trials (ie, trials analyzing either BNZ … becomes particularly
useful in this instance, as it yields a straightforward method
of simultaneously analyzing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
September 13, 2024 - No Problem: Analyzing Black Market
Sales of Atomoxetine on StreetRx. medRxiv. 2022.
9. … Analyzing Black Market Sales of the Second-Line
ADHD Medication Atomoxetine.
-
effectivehealthcare-admin.ahrq.gov/health-topics/diabetes-type-2?page=1
July 10, 2012 - Comparative Effectiveness
Overview May 3, 2012
Symposium on Methods for Developing and Analyzing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
April 01, 2013 - 1
Epoetin and Darbepoetin for Managing
Anemia in Patients Undergoing Cancer
Treatment: Comparative Effectiveness Update
Executive Summary
Background
Anemia, a deficiency in the concentration
of hemoglobin-containing red blood
cells, is prevalent among cancer patients,
depending on the type of malignancy
and t…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening
APPENDIX A FDA STATUS- SCREENING DEVICES
SE: Substantially equivalent; Premarket notification, 501(k)
Page 1 of 19
Ophthalmoscope, AC-powered
Product code: HLI
COMPANY PRODUCT FDA STATUS* APPROVAL DATE
ACCUTECH MEDICAL TECHNOLOGIES IN…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening
APPENDIX A FDA STATUS- SCREENING DEVICES
SE: Substantially equivalent; Premarket notification, 501(k)
Page 1 of 19
Ophthalmoscope, AC-powered
Product code: HLI
COMPANY PRODUCT FDA STATUS* APPROVAL DATE
ACCUTECH MEDICAL TECHNOLOGIES IN…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
November 26, 2024 - No Problem: Analyzing Black Market
Sales of Atomoxetine on StreetRx. medRxiv. 2022.
9. … Analyzing Black Market Sales of the Second-Line
ADHD Medication Atomoxetine.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
February 01, 2025 - While not useful for analyzing an existing search per se, it does provide some context of drugs,
topics
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare-admin.ahrq.gov/products/methods-balancing-harms-benefits/research-2012
November 01, 2017 - The team used that information to formulate principles for analyzing benefits and harms in systematic
-
effectivehealthcare-admin.ahrq.gov/products/stakeholders-engagement-others/white-paper
November 01, 2017 - focused on finding answers to the questions that patients most value due to challenges in collecting or analyzing